Early research (Phase 1)Looking for participantsNCT07516418
What this trial is testing
Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age
Who this might be right for
Respiratory Syncytial Virus (RSV)Influenza A(H5N1)
Sanofi 570